Clinical trialObservationalCompleted
RNA Sequencing of Solid and Cystic Lesions of the Pancreas
- Outcome
- Finished, no results posted
- Phase
- Observational
- Status
- Completed
- Study type
- Observational
- Start
- December 2012
- Ended
- December 2019
- Enrollment
- 72 participants
- Sites
- 2
- Primary outcomes
- Gene classifier that will classify lesions as benign or malignant with 95% certainty
- Sponsor type
- Academic / other
- Results posted
- No
- Last update
- 10 January 2020
These fields come from the trial’s registry entry. A summary of its population, design, endpoints and results, each tied to a quote, has not been written for this trial yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.
Try
Source text
Brief summary public domain (ClinicalTrials.gov)
The nature of cysts and solid masses in the pancreas can be difficult to diagnose. They may be benign, precancerous, or cancer. Current tests such as cytology (looking under a microscope) and tumor markers do not always give us the answer. The investigators are looking for genetic markers on biopsy specimens from the pancreas that will give us a better test for diagnosis. This study is only for diagnosing these lesions. The investigators are not treating any patients.